Molecular Imaging of Hepatocellular Carcinoma with Third-Generation US Contrast Agents: Toward Clinical Translation.
APA
Xu J (2026). Molecular Imaging of Hepatocellular Carcinoma with Third-Generation US Contrast Agents: Toward Clinical Translation.. Radiology. Imaging cancer, 8(2), e260025. https://doi.org/10.1148/rycan.260025
MLA
Xu J. "Molecular Imaging of Hepatocellular Carcinoma with Third-Generation US Contrast Agents: Toward Clinical Translation.." Radiology. Imaging cancer, vol. 8, no. 2, 2026, pp. e260025.
PMID
41790020
같은 제1저자의 인용 많은 논문 (5)
- CRISPR/Cas9 Screening Reveals that UBE2L3 Modulates Autophagic Flux through TSC2 Ubiquitination and Potentiates PD-1 Blockade in Triple-Negative Breast Cancer.
- The TRIM3/TLR3 axis overrides IFN-β feedback inhibition to suppress NSCLC progression.
- Tumor cell-intrinsic PD-1 in malignant ascites drives ovarian cancer progression via MAPK/ERK signaling.
- Pulmonary sclerosing pneumocytoma with lymph node metastasis and high FDG uptake in PET/CT: a rare case report and literature review.
- TRIM32 promotes anoikis resistance and metastasis in NSCLC by degrading CHEK2 to enhance IL-6 secretion.